Rezultati - Christophe De Block
- Showing 1 - 20 results of 39
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
Quality of Life and Glucose Control After 1 Year of Nationwide Reimbursement of Intermittently Scanned Continuous Glucose Monitoring in Adults Living With Type 1 Diabetes (FUTURE):... od Sara Charleer, Christophe De Block, Liesbeth Van Huffel, Ben Ayed B, Steffen Fieuws, Frank Nobels, Chantal Mathieu, Pieter Gillard
Izdano 2019Artigo -
12
Clinical Practice Recommendations on the Routine Use of Eversense, the First Long-Term Implantable Continuous Glucose Monitoring System od Dorothee Deiss, Agnieszka Szadkowska, Debbie Gordon, Akhila Mallipedhi, Ingrid Schütz-Fuhrmann, Eva Aguilera, Corina Ringsell, Christophe De Block, Concetta Irace
Izdano 2019Artigo -
13
Allergic contact dermatitis caused by isobornyl acrylate in <scp>F</scp>reestyle® <scp>L</scp>ibre, a newly introduced glucose sensor od Anne Herman, Olivier Aerts, Marie Baeck, M. Bruze, Christophe De Block, An Goossens, Nils Hamnerius, Sara Huygens, Dominique Maiter, Dominique Tennstedt, Bernard Vandeleene, Martin Mowitz
Izdano 2017Artigo -
14
Improving glycemic control in critically ill patients: personalized care to mimic the endocrine pancreas od J. Geoffrey Chase, Thomas Desaive, Julien Bohé, Miriam Cnop, Christophe De Block, Jan Gunst, Roman Hovorka, Pierre Kalfon, James S. Krinsley, Éric Renard, Jean‐Charles Preiser
Izdano 2018Revisão -
15
-
16
Prevalence and Prevention of Contact Dermatitis Caused by FreeStyle Libre: A Monocentric Experience od Jeroen Pyl, Ella Dendooven, Ine van Eekelen, Marieke den Brinker, Hilde Dotremont, Annick France, Kenn Foubert, Luc Pieters, Julien Lambert, Christophe De Block, Olivier Aerts
Izdano 2020Artigo -
17
Routine Sensor-Augmented Pump Therapy in Type 1 Diabetes: The INTERPRET Study od Kirsten Nørgaard, Andrea E. Scaramuzza, Nataša Bratina, Nebojša Lalić, Przemysława Jarosz‐Chobot, Győző Kocsis, Edita Jašinskienė, Christophe De Block, Odile Carrette, Javier Castañeda, for the INTERPRET Study Grou Ohad Cohen
Izdano 2013Artigo -
18
THU066 An 8-year Interim Report Of The B2412 Study, An Open-label, Multicenter Pasireotide Rollover Study For Patients Who Continued To Receive Benefit From Pasireotide At Completi... od Mônica R. Gadelha, Marcello D. Bronstein, Elena Grineva, Nitin Kapoor, Christophe De Block, Jesús Miguel Escalante Pulido, Guilherme Rollin, Rejane Baggenstoss, Andrea Piacentini, Alberto M Pedroncelli, Wilson Gallardo
Izdano 2023Artigo -
19
-
20
Iskalna orodja:
Sorodne teme
Medicine
Internal medicine
Endocrinology
Diabetes mellitus
Type 2 diabetes
Gastroenterology
Type 1 diabetes
Glycemic
Insulin
Disease
Immunology
Continuous glucose monitoring
Hormone
Acromegaly
Adverse effect
Biology
Growth hormone
Hypoglycemia
Intensive care medicine
Antibody
Genetics
Gestation
Gestational diabetes
Obstetrics
Pasireotide
Pregnancy
Prospective cohort study
Clinical endpoint
Computer science
Environmental health